D. Johnson

发表

High‐affinity binding of the cell cycle–regulated transcription factors E2F1 and E2F4 to benzo[a]pyrene diol epoxide–DNA adducts

D. Johnson, A. Coleman, K. Powell, 1997, Molecular carcinogenesis.

E2F-1 gene transfer enhances invasiveness of human head and neck carcinoma cell lines.

A. Klein-Szanto, D. Johnson, S. Y. Zhang, 2000, Cancer research.

Autoregulatory control of E2F1 expression in response to positive and negative regulators of cell cycle progression.

J. Nevins, D. Johnson, K. Ohtani, 1994, Genes & development.

A genetic analysis of the E2F1 gene distinguishes regulation by Rb, p107, and adenovirus E4.

J. Nevins, W. D. Cress, D. Johnson, 1993, Molecular and cellular biology.

The paradox of E2F1: Oncogene and tumor suppressor gene

D. Johnson, David G Johnson, David G. Johnson, 2000, Molecular carcinogenesis.

Rapid analysis of gene expression (RAGE) facilitates universal expression profiling.

D. Johnson, M. Macleod, C. M. Aldaz, 1999, Nucleic acids research.

Oncogenic capacity of the E2F1 gene.

J. Nevins, W. D. Cress, D. Johnson, 1994, Proceedings of the National Academy of Sciences of the United States of America.

Design of sensitive fluorogenic substrates for human cathepsin D

J. Collins, S. Gulnik, L. Suvorov, 1997, FEBS letters.

Regulation of both apoptosis and cell survival by the v-Src oncoprotein

W. Earnshaw, D. Johnson, M. Frame, 2000, Cell Death and Differentiation.

Deregulated expression of DP1 induces epidermal proliferation and enhances skin carcinogenesis

D. Johnson, Dawei Wang, J. Russell, 2001, Molecular carcinogenesis.

E2F1 suppresses skin carcinogenesis via the ARF-p53 pathway

D. Johnson, T. R. Berton, J. Russell, 2006, Oncogene.

Actin-binding cellular proteins inside human immunodeficiency virus type 1.

Xiao Zhen Zhou, D. Johnson, R. Fisher, 2000, Virology.

Binding properties of the human immunodeficiency virus type 1 nucleocapsid protein p7 to a model RNA: elucidation of the structural determinants for function.

R. Gorelick, J. Casas-Finet, D. Johnson, 1999, Journal of molecular biology.

Probing the topography of HIV-1 nucleocapsid protein with the alkylating agent N-ethylmaleimide.

L. Arthur, D. Johnson, E. Chertova, 1998, Biochemistry.

Cycloviolins A-D, anti-HIV macrocyclic peptides from Leonia cymosa.

L. Pannell, M. Boyd, D. Johnson, 2000, The Journal of organic chemistry.

New circulin macrocyclic polypeptides from Chassalia parvifolia.

L. Pannell, K. Gustafson, M. Boyd, 2000, Journal of natural products.

Synchronized proliferation induced by 12-O-tetradecanoylphorbol-13-acetate treatment of mouse skin: an in vivo model for cell cycle regulation.

A. Robles, D. Johnson, C. Conti, 1998, Cell growth & differentiation : the molecular biology journal of the American Association for Cancer Research.

cDNA cloning and expression of guinea pig neutrophil attractant protein-1 (NAP-1). NAP-1 is highly conserved in guinea pig.

D. Johnson, T. Yoshimura, 1993, Journal of immunology.

A genetic analysis of the E2F1 gene distinguishes regulation by Rb, p107, and adenovirus E4

J. Nevins, W. D. Cress, D. Johnson, 1993 .

Expression of the v-Src oncoprotein in fibroblasts disrupts normal regulation of the CDK inhibitor p27 and inhibits quiescence

D. Johnson, M. Frame, J. Wyke, 1998, Oncogene.

The ubiquitous octamer-binding protein(s) is sufficient for transcription of immunoglobulin genes

J. D. Capra, D. Johnson, L. Carayannopoulos, 1990, Molecular and cellular biology.

The C/EBP family of transcriptional activators is functionally important for Ig VH promoter activity in vivo and in vitro.

K. Calame, D. Johnson, P. Tucker, 1992, Journal of immunology.

Regulation of E2F-1 gene expression by p130 (Rb2) and D-type cyclin kinase activity.

D. Johnson, David G. Johnson, 1995, Oncogene.

Cyclins and cell cycle checkpoints.

D. Johnson, C. Walker, C. L. Walker, 1999, Annual review of pharmacology and toxicology.

Gag proteins of the highly replicative MN strain of human immunodeficiency virus type 1: posttranslational modifications, proteolytic processings, and complete amino acid sequences

L. Arthur, C. Fenselau, J. Bess, 1992, Journal of virology.

Contrasting effects of an Mdm2 functional polymorphism on tumor phenotypes

V. Pant, G. Lozano, S. Xiong, 2018, Oncogene.

Increased E2F1 activity induces skin tumors in mice heterozygous and nullizygous for p53.

D. Johnson, C. Conti, A. Pierce, 1998, Proceedings of the National Academy of Sciences of the United States of America.

Cytoskeletal proteins inside human immunodeficiency virus type 1 virions

L. Arthur, D. Johnson, E. Chertova, 1996, Journal of virology.

Transgenic expression of E2F3a causes DNA damage leading to ATM-dependent apoptosis

D. Johnson, C. Conti, S. Hong, 2008, Oncogene.

p53 mutations in bladder carcinoma cell lines.

S. Schwartz, G. Hatzivassiliou, D. Johnson, 1994, Oncology research.

Role of E2F in cell cycle control and cancer.

D. Johnson, R. Schneider-Broussard, D G Johnson, 1998, Frontiers in bioscience : a journal and virtual library.

Adenoviral-mediated gene transfer of ICP47 inhibits major histocompatibility complex class I expression on vascular cells in vitro.

T. Welling, D. Johnson, L. Messina, 2000, Journal of vascular surgery.

Analysis and localization of cyclophilin A found in the virions of human immunodeficiency virus type 1 MN strain.

L. Arthur, D. Johnson, R. Sowder, 1995, AIDS research and human retroviruses.

Molecular cloning and characterization of a novel mouse epidermal differentiation gene and its promoter.

D. Johnson, M. Macleod, A. Wang, 2001, Genomics.

Disruption of transcription in vitro and gene expression in vivo by DNA adducts derived from a benzo[a]pyrene diol epoxide located in heterologous sequences.

S. H. Wilson, D. Johnson, M. Macleod, 1997, Carcinogenesis.